The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10X Genomics Inc | CL A Common | 88025U109 | 2,678 | 14,798 | SH | SOLE | 14,798 | 0 | 0 | ||
Aclaris Therapeutics, Inc. | Common | 00461U105 | 41,510 | 1,647,214 | SH | SOLE | 1,647,214 | 0 | 0 | ||
Akero Therapeutics Inc | Common | 00973Y108 | 19,532 | 673,280 | SH | SOLE | 673,280 | 0 | 0 | ||
Aligos Therapeutics Inc | Common | 01626L105 | 80,659 | 3,547,030 | SH | SOLE | 3,547,030 | 0 | 0 | ||
ALX Oncology Holdings Inc | Common | 00166B105 | 311,186 | 4,220,048 | SH | SOLE | 4,220,048 | 0 | 0 | ||
Amyris, Inc | Common | 03236M200 | 251,391 | 13,161,847 | SH | SOLE | 13,161,847 | 0 | 0 | ||
Arcutis Biotherapeutics Inc | Common | 03969K108 | 21,535 | 744,370 | SH | SOLE | 744,370 | 0 | 0 | ||
Arrowhead Pharmaceuticals Inc | Common | 04280A100 | 9,112 | 137,411 | SH | SOLE | 137,411 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 214,488 | 1,664,242 | SH | SOLE | 1,664,242 | 0 | 0 | ||
Aslan Pharmaceuticals Ltd | ADS | 04522R101 | 9,517 | 2,840,909 | SH | SOLE | 2,840,909 | 0 | 0 | ||
Atricure Inc | Common | 04963C209 | 4,231 | 64,573 | SH | SOLE | 64,573 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 6,502 | 500,732 | SH | SOLE | 500,732 | 0 | 0 | ||
Avadel Pharmaceuticals PLC | ADR | 05337M104 | 26,551 | 2,937,093 | SH | SOLE | 2,937,093 | 0 | 0 | ||
Bolt Therapeutics Inc | Common | 097702104 | 127,404 | 3,871,291 | SH | SOLE | 3,871,291 | 0 | 0 | ||
Calliditas Therapeutics ADR | SPONSORED ADS | 13124Q106 | 8,574 | 311,030 | SH | SOLE | 311,030 | 0 | 0 | ||
Celldex Therapeutics Inc | Common | 15117B202 | 26,613 | 1,291,875 | SH | SOLE | 1,291,875 | 0 | 0 | ||
Chinook Therapeutics Inc | Common | 16961L106 | 18,745 | 1,206,266 | SH | SOLE | 1,206,266 | 0 | 0 | ||
Codexis, Inc | Common | 192005106 | 8,885 | 388,144 | SH | SOLE | 388,144 | 0 | 0 | ||
Constellation Pharmaceutical | Common | 210373106 | 3,282 | 140,298 | SH | SOLE | 140,298 | 0 | 0 | ||
Crinetics Pharmaceuticals Inc | Common | 22663K107 | 33,832 | 2,214,138 | SH | SOLE | 2,214,138 | 0 | 0 | ||
Cullinan Management Inc | Common | 230031106 | 10,418 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Curis Inc | Common | 231269200 | 17,586 | 1,553,500 | SH | SOLE | 1,553,500 | 0 | 0 | ||
Cytokinetics Inc | Common | 23282W605 | 16,282 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
Design Therapeutics | Common | 25056L103 | 15,877 | 530,991 | SH | SOLE | 530,991 | 0 | 0 | ||
Dyne Therapeutics Inc | Common | 26818M108 | 8,971 | 577,642 | SH | SOLE | 577,642 | 0 | 0 | ||
Eiger BioPharmaceuticals Inc | Common | 28249U105 | 15,853 | 1,791,257 | SH | SOLE | 1,791,257 | 0 | 0 | ||
Essa Pharma Inc | Common | 29668H708 | 60,102 | 2,068,907 | SH | SOLE | 2,068,907 | 0 | 0 | ||
Genetron Holdings Ltd | ADS | 37186H100 | 136,053 | 6,339,860 | SH | SOLE | 6,339,860 | 0 | 0 | ||
Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | 23,454 | 1,522,994 | SH | SOLE | 1,522,994 | 0 | 0 | ||
Harmony Biosciences Holdings Inc | Common | 413197104 | 149,815 | 4,534,341 | SH | SOLE | 4,534,341 | 0 | 0 | ||
Homology Medicines, Inc. | Common | 438083107 | 8,028 | 853,143 | SH | SOLE | 853,143 | 0 | 0 | ||
IGM Biosciences Inc | Common | 449585108 | 1,534 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Immunovant Inc | Common | 45258J102 | 8,547 | 532,847 | SH | SOLE | 532,847 | 0 | 0 | ||
Instil Bio Inc | Common | 45783C101 | 313,169 | 12,486,787 | SH | SOLE | 12,486,787 | 0 | 0 | ||
Iveric Bio Inc | Common | 46583P102 | 36,873 | 5,966,527 | SH | SOLE | 5,966,527 | 0 | 0 | ||
Kadmon Holdings Inc | Common | 48283N106 | 22,630 | 5,817,459 | SH | SOLE | 5,817,459 | 0 | 0 | ||
Kala Pharmaceuticals, Inc. | Common | 483119103 | 5,304 | 786,883 | SH | SOLE | 786,883 | 0 | 0 | ||
KalVista Pharmaceuticals Inc. | Common | 483497103 | 47,868 | 1,863,296 | SH | SOLE | 1,863,296 | 0 | 0 | ||
Kura Oncology Inc | Common | 50127T109 | 14,849 | 525,262 | SH | SOLE | 525,262 | 0 | 0 | ||
Larimar Therapeutics Inc | Common | 517125100 | 11,683 | 799,662 | SH | SOLE | 799,662 | 0 | 0 | ||
Legend Biotech Corp Sponsored | SPONSORED ADS | 52490G102 | 79,950 | 2,755,007 | SH | SOLE | 2,755,007 | 0 | 0 | ||
Mereo Biopharma Group PLC | ADS | 589492107 | 14,225 | 4,220,938 | SH | SOLE | 4,220,938 | 0 | 0 | ||
Merus NV | Common | N5749R100 | 3,656 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
Metacrine Inc | Common | 59101E103 | 908 | 146,426 | SH | SOLE | 146,426 | 0 | 0 | ||
New Frontier Health Corp | Ord Shs | G6461G106 | 161,590 | 14,300,000 | SH | SOLE | 14,300,000 | 0 | 0 | ||
Nkarta Inc | Common | 65487U108 | 16,852 | 512,225 | SH | SOLE | 512,225 | 0 | 0 | ||
Novavax Inc | Common | 670002401 | 28,554 | 157,487 | SH | SOLE | 157,487 | 0 | 0 | ||
Olema Pharmaceuticals Inc | Common | 68062P106 | 41,096 | 1,238,575 | SH | SOLE | 1,238,575 | 0 | 0 | ||
Orchard Therapeutics plc | ADS | 68570P101 | 9,625 | 1,325,736 | SH | SOLE | 1,325,736 | 0 | 0 | ||
Passage Bio Inc | Common | 702712100 | 24,708 | 1,413,508 | SH | SOLE | 1,413,508 | 0 | 0 | ||
Precision Biosciences Inc | Common | 74019P108 | 1,452 | 140,255 | SH | SOLE | 140,255 | 0 | 0 | ||
Satsuma Pharmaceuticals Inc | Common | 80405P107 | 7,283 | 1,232,394 | SH | SOLE | 1,232,394 | 0 | 0 | ||
Sierra Oncology, Inc | Common | 82640U404 | 33,031 | 1,917,074 | SH | SOLE | 1,917,074 | 0 | 0 | ||
Sinovac Biotech Ltd. | SHS | P8696W104 | 38,173 | 5,900,000 | SH | SOLE | 5,900,000 | 0 | 0 | ||
Syndax Pharmaceuticals Inc | Common | 87164F105 | 7,155 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
Tarsus Pharmaceuticals Inc | Common | 87650L103 | 104,587 | 3,245,035 | SH | SOLE | 3,245,035 | 0 | 0 | ||
Terns Pharmaceuticals Inc | Common | 880881107 | 58,853 | 2,675,133 | SH | SOLE | 2,675,133 | 0 | 0 | ||
Tricida, Inc. | Common | 89610F101 | 924 | 174,763 | SH | SOLE | 174,763 | 0 | 0 | ||
Verona Pharma PLC ADR | ADS | 925050106 | 25,486 | 3,048,507 | SH | SOLE | 3,048,507 | 0 | 0 | ||
VYNE Therapeutics Inc | Common | 92941V100 | 1,608 | 234,877 | SH | SOLE | 234,877 | 0 | 0 | ||
Zai Lab Ltd ADR | ADR | 98887Q104 | 23,350 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
Zogenix Inc | Common | 98978L204 | 2,050 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
Zymeworks Inc | Common | 98985W102 | 9,034 | 286,064 | SH | SOLE | 286,064 | 0 | 0 |